Plasma proteomic profiling reveals distinct protein signatures associated with hepatocellular carcinoma in chronic hepatitis B infection

Key Points

• Distinct protein signatures are identified in the plasma of individuals with hepatocellular carcinoma and chronic hepatitis B.
• The biomarkers observed may aid in the early detection and diagnosis of liver cancer associated with chronic hepatitis.
• Analysis utilized advanced proteomic profiling techniques to examine plasma samples from affected individuals.
• Findings highlight the importance of specific protein markers that may improve targeted healthcare strategies in managing liver diseases.